Document is current
Any future updates will be listed below
-
Authors
Iba, Toshiaki https://orcid.org/0000-0002-0255-4088
Yamakawa, Kazuma https://orcid.org/0000-0003-2999-4021
Shiko, Yuki https://orcid.org/0000-0002-3959-9343
Hisamune, Ryo https://orcid.org/0009-0009-3339-1902
Tanigawa, Tomoki
Helms, Julie https://orcid.org/0000-0003-0895-6800
Levy, Jerrold H. https://orcid.org/0000-0003-3766-4962
- License Information
-
More Information
Article History
Received: 30 April 2024
Accepted: 18 June 2024
First Online: 24 June 2024
Declarations
:
: The study received ethical approval from the Institutional Review Board of Juntendo University, the Japan Blood Products Organization, and Osaka General Medical Center (#25-2050).
: Not applicable.
: TI has participated in advisory boards of Japan Blood Products Organization, Toray Medical, and Asahi Kasei Pharmaceuticals and received a research grant from JIMRO. KY received grants from Asahi Kasei Pharma and Nihon Pharmaceutical. JH received honoraria from Diagnostica Stago, Pfizer PFE France, Sanofi Aventis France, MSD, Shionogi, and Inotrem. JHL serves on the Steering or Advisory Committees for Instrumentation Laboratories, Merck, Octapharma. The other authors have no conflict of interest.
